Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study

G. Forouhi, Nita; Koulman, Albert; J. Sharp, Stephen; Imamura, Fumiaki; Kröger, Janine; B. Schulze, Matthias; L. Crowe, Francesca; María Huerta, José; Guevara, Marcela; W. J. Beulens, Joline; J. van Woudenbergh, Geertruida; Wang, Laura; Summerhill, Keith; L. Griffin, Julian; J. M. Feskens, Edith; Amiano, Pilar; Boeing, Heiner; Clavel‐Chapelon, Françoise; Dartois, Laureen; Fagherazzi, Guy; W. Franks, Paul; A. González, Carlos; Uhre Jakobsen, Marianne; Kaaks, Rudolf; J. Key, Timothy; Khaw, Kay‐Tee; Kühn, Tilman; Mattiello, Amalia; M. Nilsson, Peter; Overvad, Kim; Pala, Valeria; Palli, Domenico; Ramón Quirós, J.; Rolandsson, Olov; Roswall, Nina; Sacerdote, Carlotta; Sánchez, María‐José; Slimani, Nadia; M. W. Spijkerman, Annemieke; Tjønneland, Anne; Tormo, María‐José; ­Tumino, ­Rosario; L. van der A, Daphne; T. van der Schouw, Yvonne; Langenberg, Claudia; Ríboli, Elio; J. Wareham, Nicholas

doi:10.1016/s2213-8587(14)70146-9

Public

Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study

Published in The Lancet Diabetes & Endocrinology • Aug 5, 2014

Authors:

Nita G. Forouhi

Albert Koulman

Stephen J. Sharp

Abstract

BACKGROUND: Conflicting evidence exists regarding the association between saturated fatty acids (SFAs) and type 2 diabetes. In this longitudinal case-cohort study, we aimed to investigate the prospective associations between objectively measured individual plasma phospholipid SFAs and incident type ...

Subject

Medicine

Prospective cohort study

Type 2 diabetes

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!